Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001205
Filing Date
2025-05-13
Accepted
2025-05-13 07:02:51
Documents
53
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clrb-20250331x10q.htm   iXBRL 10-Q 1022851
2 EX-31.1 clrb-20250331xex31d1.htm EX-31.1 10882
3 EX-31.2 clrb-20250331xex31d2.htm EX-31.2 10880
4 EX-32.1 clrb-20250331xex32d1.htm EX-32.1 9074
  Complete submission text file 0001410578-25-001205.txt   4884995

Data Files

Seq Description Document Type Size
5 EX-101.SCH clrb-20250331.xsd EX-101.SCH 35853
6 EX-101.CAL clrb-20250331_cal.xml EX-101.CAL 31358
7 EX-101.DEF clrb-20250331_def.xml EX-101.DEF 179568
8 EX-101.LAB clrb-20250331_lab.xml EX-101.LAB 284760
9 EX-101.PRE clrb-20250331_pre.xml EX-101.PRE 255971
56 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20250331x10q_htm.xml XML 696834
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 25937088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)